Abstract
Background & Objective: Notoginsenoside R1 (NGR1) is one of the main effective components of Panax notoginseng.
Method: Primary cortical neurons were harvested from neonatal rats and cultured to analyze the role of NGR1 in neuronal growth and the effects of NGR1 on the Wnt/β-catenin signaling pathway. Following treatment with NGR1, immunocytochemistry was used to detect expression of Tuj1 and MAP2, and RT-qPCR was used to measure mRNA levels of key factors in the Wnt signaling pathway.
Results: Results showed that NGR1 promotes growth of cultured neurons and significantly upregulates mRNA levels of β-catenin, Dishevelled, and Frizzled. To further confirm whether NGR1 promoted cortical neuron growth via the Wnt/β-catenin signaling pathway, we knocked down β- catenin mRNA by siRNA interference; following NGR1 treatment of β-catenin-knockdown neurons, β-catenin mRNA levels increased significantly.
Conclusion: In conclusion, these results demonstrate that NGR1 promotes growth of cultured cortical neurons from the neonatal rat, possibly via the Wnt/β-catenin signaling pathway.
Keywords: Wnt/β-catenin signaling pathway, β-catenin, NGR1, growth, cortical neuron, RNA interference.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Notoginsenoside R1 Promotes the Growth of Neonatal Rat Cortical Neurons via the Wnt/β-catenin Signaling Pathway
Volume: 17 Issue: 7
Author(s): Xing-Tong Li, Wei Ma, Xian-Bin Wang, Zhang Liang, Jin-Wei Yang, Yuan He, Yun-Fei Dai, Tong Zhang, Jia-Wei Wang, Kuang-Pin Liu, Xiang-Peng Wang, Xing-Kui Zhang, Chun-Yan Li, Jun-Jun Li, Hong-Yan Tang, Ping Su*, Jian-Hui Guo*Li-Yan Li*
Affiliation:
- Department of Neurosurgery, First People`s Hospital of Kunming City, Yunnan Kunming,China
- Second Department of General Surgery, First People`s Hospital of Yunnan Province, Yunnan Kunming,China
- Institute of Neuroscience, Kunming Medical University, Yunnan Kunming,China
Keywords: Wnt/β-catenin signaling pathway, β-catenin, NGR1, growth, cortical neuron, RNA interference.
Abstract: Background & Objective: Notoginsenoside R1 (NGR1) is one of the main effective components of Panax notoginseng.
Method: Primary cortical neurons were harvested from neonatal rats and cultured to analyze the role of NGR1 in neuronal growth and the effects of NGR1 on the Wnt/β-catenin signaling pathway. Following treatment with NGR1, immunocytochemistry was used to detect expression of Tuj1 and MAP2, and RT-qPCR was used to measure mRNA levels of key factors in the Wnt signaling pathway.
Results: Results showed that NGR1 promotes growth of cultured neurons and significantly upregulates mRNA levels of β-catenin, Dishevelled, and Frizzled. To further confirm whether NGR1 promoted cortical neuron growth via the Wnt/β-catenin signaling pathway, we knocked down β- catenin mRNA by siRNA interference; following NGR1 treatment of β-catenin-knockdown neurons, β-catenin mRNA levels increased significantly.
Conclusion: In conclusion, these results demonstrate that NGR1 promotes growth of cultured cortical neurons from the neonatal rat, possibly via the Wnt/β-catenin signaling pathway.
Export Options
About this article
Cite this article as:
Li Xing-Tong, Ma Wei, Wang Xian-Bin, Liang Zhang, Yang Jin-Wei, He Yuan, Dai Yun-Fei, Zhang Tong, Wang Jia-Wei, Liu Kuang-Pin, Wang Xiang-Peng, Zhang Xing-Kui, Li Chun-Yan, Li Jun-Jun, Tang Hong-Yan, Su Ping*, Guo Jian-Hui*, Li Li-Yan*, Notoginsenoside R1 Promotes the Growth of Neonatal Rat Cortical Neurons via the Wnt/β-catenin Signaling Pathway, CNS & Neurological Disorders - Drug Targets 2018; 17 (7) . https://dx.doi.org/10.2174/1871527317666180711093538
DOI https://dx.doi.org/10.2174/1871527317666180711093538 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Steroidal Anti-Inflammatory Drugs used as a Treatment Modality in Subarachnoid Hemorrhage
Current Drug Safety Immune System Modulators with Antidepressant Effects: Evidence from Animal Models
CNS & Neurological Disorders - Drug Targets Brain Information Sharing During Visual Short-Term Memory Binding Yields a Memory Biomarker for Familial Alzheimer's Disease
Current Alzheimer Research Inactivation of Parathyroid Hormone: Perspectives of Drug Discovery to Combating Hyperparathyroidism
Current Molecular Pharmacology A Comprehensive Review on Pharmacognostical Investigation and Pharmacology of Typhonium trilobatum
The Natural Products Journal Vasorelaxant and Antihypertensive Effects of <i>Mentha pulegium</i> L. in Rats: An In vitro and In vivo Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases
Current Topics in Medicinal Chemistry Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets Editorial [Disparity in Pharmacotherapies]
Current Drug Therapy Neuroprotective Effects of Extracts from the Radix Curcuma aromatica on H2O2-induced Damage in PC12 Cells
Combinatorial Chemistry & High Throughput Screening The Orexinergic (Hypocretin) System and Nociception: An Update to Supraspinal Mechanisms
Current Medicinal Chemistry A Comparison of Neurocognitive Decline in Older Adults in Same-Sex and Opposite-Sex Relationships
Current Alzheimer Research Strategies to In Vitro Assessment of Major Human CYP Enzyme Activities by Using Liquid Chromatography Tandem Mass Spectrometry
Current Drug Metabolism Medications Acting on the Dopaminergic System in the Treatment of Alcoholic Patients
Current Pharmaceutical Design Short-Term Response to Cholinesterase Inhibitors in Alzheimer’s Disease Delays Time to Nursing Home Placement
Current Alzheimer Research Serum IL-33 Level and IL-33, IL1RL1 Gene Polymorphisms in Asthma and Multiple Sclerosis Patients
Current Molecular Medicine The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases
Current Neuropharmacology Acetylcholinesterase-Amyloid-β-peptide Interaction: Effect of Congo Red and the Role of the Wnt Pathway
Current Alzheimer Research Frailty among HIV-1 Infected Adults under Antiretroviral Therapy in Indonesia
Current HIV Research